Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for GBLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2024 0.003M
September 30, 2024 0.0023M
June 30, 2024 0.00
March 31, 2024 0.012M
December 31, 2023 0.0175M
September 30, 2023 0.1045M
June 30, 2023 0.0296M
March 31, 2023 0.1099M
December 31, 2022 0.274M
September 30, 2022 0.6578M
June 30, 2022 0.054M
March 31, 2022 0.2339M
December 31, 2021 1.504M
September 30, 2021 0.3953M
June 30, 2021 0.583M
March 31, 2021 0.793M
December 31, 2020 0.7711M
September 30, 2020 0.545M
June 30, 2020 0.1012M
March 31, 2020 0.0024M
December 31, 2019 0.0373M
September 30, 2019 0.0848M
June 30, 2019 0.1413M
March 31, 2019 0.1821M
December 31, 2018 0.3241M
Date Value
September 30, 2018 2.929M
June 30, 2018 4.659M
March 31, 2018 3.580M
December 31, 2017 1.487M
September 30, 2017 0.9713M
June 30, 2017 1.454M
March 31, 2017 2.693M
December 31, 2016 0.9913M
September 30, 2016 2.072M
June 30, 2016 0.1783M
March 31, 2016 0.0348M
December 31, 2015 0.0667M
September 30, 2015 0.345M
June 30, 2015 0.3328M
March 31, 2015 0.00
December 31, 2014 0.2821M
September 30, 2014 1.638M
June 30, 2014 3.213M
March 31, 2014 0.3393M
December 31, 2013 0.0001M
September 30, 2013 0.00
June 30, 2013 0.0175M
March 31, 2013 0.0024M
December 31, 2012 0.00
September 30, 2012 0.00

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. 2.244M
CNBX Pharmaceuticals, Inc. 0.0095M
Arvinas, Inc. 567.90M
Fulcrum Therapeutics, Inc. 318.84M
Definium Therapeutics, Inc. 1.084B